Kenneth C. Cundy
2021 - CohBar
In 2021, Kenneth C. Cundy earned a total compensation of $566.9K as Former Chief Scientific Officer at CohBar, a 22% increase compared to previous year.
Compensation breakdown
| Option Awards | $208,200 |
|---|---|
| Salary | $350,000 |
| Other | $8,700 |
| Total | $566,900 |
Cundy received $350K in salary, accounting for 62% of the total pay in 2021.
Cundy also received $208.2K in option awards and $8.7K in other compensation.
Rankings
In 2021, Kenneth C. Cundy's compensation ranked 10,448th out of 12,415 executives tracked by ExecPay. In other words, Cundy earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,448 out of 12,415 | 16th |
Division Manufacturing | 4,624 out of 5,505 | 16th |
Major group Chemicals And Allied Products | 2,071 out of 2,375 | 13th |
Industry group Drugs | 1,837 out of 2,096 | 12th |
Industry Pharmaceutical Preparations | 1,363 out of 1,546 | 12th |
Source: SEC filing on April 22, 2022.
Cundy's colleagues
We found three more compensation records of executives who worked with Kenneth C. Cundy at CohBar in 2021.
News
Anebulo Pharmaceuticals CEO Simon Allen's 2023 pay falls 63% to $778K
October 30, 2023
Anebulo Pharmaceuticals CEO Simon Allen receives $2.1M in 2022
October 17, 2022
CohBar CEO Joseph Sarret receives $3.2M in 2021
April 22, 2022
CohBar CEO Steven Engle receives $2.4M in 2019
April 29, 2020
CohBar CEO Philippe Calais receives $1.6M in 2018
April 24, 2019